Pages

Labels

Monday 26 March 2018

VR MED - The first VR solution in MedTech

   VR MED is the first medical device in the world to employ VR technology for a wide range of uses. It has similar success not only in ophthalmology, but also neurology and rehabilitation. All you need for the transformation is to put in the required software and configure the system. There is no need to change the device itself. Just one set of equipment covers a large part of the clinic’s needs with VR technology.

   The development of a new approach to patient diagnosis and treatment is ongoing. Patented technology. The VRMD card will be the platform's internal currency, allowing users to acquire software to extend gadget functionality and support new development on the platform.

   VR MED software and hardware for screening in the field of ophthalmology were tested at the Eye Diseases Institute of the Russian Academy of Sciences and Fah Aachen University of Applied Sciences, Germany. Currently, VR helmets can replace 40% of all specialist eye specialist clinics, which cost less than six times the "Gold Standard" device.

   The VR MED headset provides visual field analysis to enable doctors to diagnose early-stage glaucoma. The initial auditory test, completed at Fah Aachen University of Applied Sciences, has confirmed the uniqueness and innovation of this product. The device is currently being tested at the Eye Institute at the Russian Academy of Sciences.

 
Ergonomic Design
   
   VR MED is integrated into the headset with ergonomic design, which is different from the competition, offering greater accuracy in fast track speeds. This allows headset flexibility to be used in a variety of medical settings.

   All you need to produce results: put in the appropriate software and configure the system VR MED is the first medical device in the world to employ VR technology for a wide range of uses. It has similar success not only in ophthalmology, but also neurology and rehabilitation. All you need for the transformation is to put in the required software and configure the system. There is no need to change the device itself. Just one set of equipment covers a large part of the clinic’s needs with VR technology.

VRMED Token is a local currency platform that allows owners

  • Get the product and use the right service at a lower price than the fiat currency
  • Get access to software updates, expand headset functionality, buy and sell data.
  • Involve fundraising for new medical development for VR MED headsets. The growing demand  for tokens will depend on growing demand for equipment and updates.

  •    Blockchain is the basis of fpatform. VRMD-tokens is an internal payment facility that will ensure interaction between participants. Smart payment automation contract between clinic and developer. In addition, they will make it possible to adjust the relationship between developers and investors, make financial statements, as well as conditions for the distribution of profits and profits from those funds. Therefore, the basis of VR MED blockers eliminates unnecessary intermediaries, and creates the necessary infrastructure to maximize the efficiency of ecosystem development.
       Blockchain technology, including tags provided in Token Processes, is actively being discussed by regulatory bodies from various countries, however, the legislative basis, in particular all aspects Legal aspects of this phenomenon have not been established, including card issuing procedures, legal nature, registration requirements, consequences of breach of publishing procedure. Thus, the operation and concept of the VR MED platform can be dramatically changed as a result of the new law on currency revenues.

       The open protocol of the VR MED platform implies additional risks associated with the project's security information. The VR MED team claims that they will do their best to prevent potential hackers from attacking the system, but will not be liable for any damages caused by such malicious actions. In addition, project codecs will be provided on the Etherium platform, and disruptions in their operations may have a significant negative impact on the performance of VRMD tokens.

    VRMED Token                                                    Distribution of VRMD-tokens

    > Token ERC 20 Protocol                                      > 20,000,000 VRMD  – Crowd sale
    > Quantity        30 000 000 Tokens                        > 4,000,000 VRMD  –  Team, bounty, marketing
    > Price             0.25 USD = 1 Token VRMD         >  6,000,000 VRMD  – Reserve
    > Buy with       BTC   ETH   USD

    VRMD Token is an internal currency platform which allows holders to:

       Acquire a product and access to services for a reduced price in comparison to with fiat currency
    Acquire access to update software, widen the functional capabilities of the headset, buying and selling data.

       Take part in fundraising for new medical developments for the VR MED headset Growth of demand for the tokens will depend on growth of demand for the device and updates.

    Roadmap

    Before ICO
       Start of the development of VR headset and programming suitable for medical use.

    06.2016
    Patent granted in Russia.
    Start of process to receive international patents

    12.16 - 02.17
    Creation of pilot model of equipment and software for screening for glaucoma and other conditions with peripheral vision defects.
    Successful experimental outcomes in the Institute of Eye Diseases at the Russian Academy of Sciences

    02.17 - 04.17
    Participation at international presentations in Lisbon and Bahrain. Introduction of the device

    04.17
    Successful approval process for the device and software at the FH Aachen University of Applied Sciences

    05.17-07.17
    Development of the Alpha version of the device, with capability of providing solutions in ophthalmology (measurement of peripheral vision, diagnosis of glaucoma markers)
    07.17-10.17

       After ICO
    Start of the development of VR headset and programming suitable for medical use.

    06.2016
    Patent granted in Russia.
    Start of process to receive international patents

    12.16 - 02.17
    Creation of pilot model of equipment and software for screening for glaucoma and other conditions with peripheral vision defects.
    Successful experimental outcomes in the Institute of Eye Diseases at the Russian Academy of Sciences

    02.17 - 04.17
    Participation at international presentations in Lisbon and Bahrain. Introduction of the device

    04.17
    Successful approval process for the device and software at the FH Aachen University of Applied Sciences

    05.17-07.17
    Development of the Alpha version of the device, with capability of providing solutions in ophthalmology (measurement of peripheral vision, diagnosis of glaucoma markers)
    07.17-10.17

    Development of the device final version
    (technical and usage fine-tuning), construct improvements

    03.18 - 06.18
    Standard ISO 12866-2011. Industrial design development

    06.18 - 08.18
    Certification of software "Perimeter": Creation of a universal design for the diagnosis of a range of visual functions (through early diagnosis of glaucoma and other peripheral vision field defects)

    08.18 - 12.18
    Entrance to the world market: Undergo approval process in India and China clinics; obtain international ISO certification

    04.18 - 09.18
    Upload of users' data to the platform. Distribution of the device in the European Union, Russia and Asia;
    Launch of decentralized platform;
    The 100% functional Perimeter becomes the "gold standard" in ophthalmic diagnosis

    05.18 - 07.19
    Widening of device functionality to include usage in neurology and rehabilitation
    05.18 - 07.19




    Forum Username     :  olitaptapan
    Wallet Address         :  0x4D301c9357A384C1aF2F4ef3418C97F16d9043d8 

    No comments:

    Post a Comment

    thanks udah koment blog saya